(Q38469087)

English

The effect of rosiglitazone on LRP1 expression and amyloid β uptake in human brain microvascular endothelial cells: a possible role of a low-dose thiazolidinedione for dementia treatment

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

The effect of rosiglitazone on LRP1 expression and amyloid β uptake in human brain microvascular endothelial cells: a possible role of a low-dose thiazolidinedione for dementia treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

0 references

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

author name string

Jae Hoon Moon

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Hyung Jun Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Ae Hee Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Hyun Min Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Byung-Wan Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Eun Seok Kang

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Hyun Chul Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Bong Soo Cha

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

1 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

The International Journal of Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

135-142

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

The role of the low-density lipoprotein receptor-related protein (LRP1) in Alzheimer's A beta generation: development of a cell-based model system.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

LRP: a multifunctional scavenger and signaling receptor

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Gemfibrozil considerably increases the plasma concentrations of rosiglitazone

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Clearance of amyloid-beta by circulating lipoprotein receptors

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Transporters in the brain endothelial barrier.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001611

21 January 2018

Identifiers

10.1017/S1461145711001611

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38469087&oldid=1761256803"